Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-22T17:58:58.006Z Has data issue: false hasContentIssue false
  • English
  • Français

Long-term treatment of depression

Published online by Cambridge University Press:  16 April 2020

Y Lecrubier
Y Lecrubier*
Affiliation:
Hôpital de la Pitié-Salpêtrière, Pavillon Clérambault, 47, bd de l'Hôpital, 75013Paris, France
Get access

Summary

Long-term treatment with antidepressants is now an accepted strategy in the management of depression. The demonstration of efficacy in this setting requires specific placebo-controlled trials of patients with recurrent depression studied after an adequate period of euthymia and for a long period of follow-up. This review examines the evidence for the prophylactic efficacy of antidepressant therapy with particular emphasis on the selective serotonin reuptake inhibitor, paroxetine.

Keywords

paroxetineSSRItricyclicmaprotilinephenelzinelong-termprophylaxis
Type
Research Article
Information
European Psychiatry , Volume 8 , Issue S1: New perspectives in the pharmacological treatment of depression. Defining the ideal antidepressant. 3 November 1992, Barcelona, Spain , 1993 , pp. 13s - 16s
Copyright
Copyright © Elsevier, Paris 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Angst, J (1990) Natural history and epidemiology of depressionIn: Current Approaches (Cobb, JGoeting, N eds). Duphar Medical Relations, Southampton111Google Scholar
Coppen, AGhose, KMontgomery, SARama Rao, VABailey, JJorgensen, A (1978) Continuation therapy with amitriptyline in depression Br J Psychiatry 133, 28–33CrossRefGoogle ScholarPubMed
Doogan, DPCaillard, V (1992) Sertraline in the prevention of depression Br J Psychiatry 160, 217–222CrossRefGoogle ScholarPubMed
Frank, EKupfer, DJPerel, JMCornes, CJarrett, DBMallinger, AGThase, MEMcEachran, ABGrochocinski, VJ (1990) Three-year outcomes for maintenance therapies in recurrent depression Arch Gen Psychiatry 47,1093–1099CrossRefGoogle ScholarPubMed
Frank, EPrien, RFJarrett, RBWeller, MBKupfer, DJLavori, PWRush, AJWeissman, MM (1991) Conceptualization and rationale for consensus definitions of terms in major depressive episodes Arch Gen Psychiatry 48, 851–855CrossRefGoogle Scholar
Georgotas, AMcCue, RECooper, TB (1989) A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients Arch Gen Psychiatry 46 (suppl 8), 46–51Google ScholarPubMed
Glen, AIMJohnson, ALShepherd, M (1984) Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial Psychol Med 14, 37–50CrossRefGoogle ScholarPubMed
Kane, JMQuitkin, FMRifkin, ARamos Lorenzi, JRNayak, DDHoward, A (1982) Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness - a prospective, placebo-controlled comparison Arch Gen Psychiatry 39, 1065–1069CrossRefGoogle ScholarPubMed
Mindham, RHSHowland, OShepherd, M (1973) An evaluation of continuation therapy with tricyclic antidepressants in depressive illness Psychol Med 3, 5–17CrossRefGoogle ScholarPubMed
Montgomery, SA (1989) Prophylaxis in recurrent unipolar depression: a new indication for treatment studies J Psychopharmacol 3 (suppl 2), 47–53CrossRefGoogle ScholarPubMed
Montgomery, SADufour, HBrion, SGailledreau, JLaqueille, XFerrey, GMoron, PParant Lucena, NSinger, LDanion, JM (1988) The prophylactic efficacy of fluoxetine in unipolar depression Br J Psychiatry 153 (suppl 3), 69–76CrossRefGoogle Scholar
Montgomery, SAMontgomery, DB (1992) Prophylactic treatment in recurrent unipolar depressionIn: Long-term Treatment of Depression. Perspectives in Psychiatry Vol.3 (Montgomery, SRouillon, F eds). Wiley and Sons, Chichester, 53–79Google Scholar
Peselow, EDDunner, DLFieve, RRDifiglia, C (1991) The prophylactic efficacy of tricyclic antidepressants - a five year follow up Prog Neuro-Psychopharmacol Biol Psychiatry 15,71–82CrossRefGoogle Scholar
Prien, RFKlett, CJCaffey, EM (1973) Lithium carbonate and imipramine in the prevention of affective episodes Arch Gen Psychiatry 29,420–425CrossRefGoogle ScholarPubMed
Prien, RKKupfer, DJMansky, PASmall, JGTuason, VBVoss, CBJohnson, WE (1984) Drug therapy in the prevention of recurrence in unipolar and bipolar affective disorders Arch Gen Psychiatry 41, 1096–1104CrossRefGoogle ScholarPubMed
Robinson, DSLerfald, SCBennett, BLaux, DDevereaux, EKayser, ACorcella, JAlbright, D (1991) Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind, placebo-controlled discontinuation study Psychopharmacol Bull 27, 31–39Google Scholar
Rouillon, FSerrurier, DMiller, HDGerard, M-J (1991) Prophylactic efficacy of maprotiline on unipolar depression relapse J Clin Psychiatry 52, 423–431Google ScholarPubMed
Souza, FGMGoodwin, GM (1991) Lithium treatment and prophylaxis in unipolar depression: a meta-analysis Br J Psychiatry 158,666–675CrossRefGoogle ScholarPubMed
WHO Mental Health Collaborating Centre: consensus statement (1989) J Affective Disord 17,197–198CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.